With the exception of IBD patients, the upregulated expression of SLAMF7 was detected in patients with acute and chronic inflammation,18 such as those with rheumatoid arthritis and COVID-19 pneumonia, indicating the extensive role of SLAMF7 in regulating the inflammatory response. Here, SLAMF7 is linked to inflammatory bowel disease.